deltatrials
Terminated EARLY_PHASE1 INTERVENTIONAL 2-arm NCT02748798

Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders

Developing Optimal Parameters for Hyperpolarized Noble Gas (3He and 129Xe) and Inert Fluorinated Gas Magnetic Resonance Imaging of Lung Disorders

Sponsor: Lakehead University

Conditions Asbestosis Asthma Bronchiectasis Chronic Obstructive Pulmonary Disease Cold Virus Cystic Fibrosis Emphysema Interstitial Lung Disease Lung Cancer Lung Infection Lung Resection Lung Transplant Mesothelioma Obstructive Sleep Apnea Pulmonary Dysplasia Pulmonary Embolism Pulmonary Fibrosis Pulmonary Hypertension Seasonal Allergies
Interventions 129Xe Small and Large Human Lung Coil 3He Human Lung Coil HP 129Xe HP 3He PFP PFP and SF6 Human Lung Coil SF6
Updated 14 times since 2017 Last updated: Oct 8, 2024 Started: Nov 10, 2020 Primary completion: Oct 16, 2021 Completion: Oct 16, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Funding is no longer available due to the failure to enroll the target number of participants within the required timeframe.

Other terminated trials from Lakehead University

See all terminations from Lakehead University

This EARLY_PHASE1 trial investigates Asbestosis and Asthma and is currently terminated or withdrawn. Lakehead University leads this study, which shows 14 recorded versions since 2020 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Nov 2017 · 9 months · monthly snapshot~Nov 2017 – ~Jun 2018 · 7 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Sep 2018 · 2 months · monthly snapshot~Sep 2018 – ~May 2019 · 8 months · monthly snapshot~May 2019 – ~Oct 2020 · 17 months · monthly snapshot~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshot~Jan 2021 – ~Nov 2022 · 22 months · monthly snapshot~Nov 2022 – ~May 2023 · 6 months · monthly snapshot~May 2023 – ~Jul 2024 · 14 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Nov 2024 · 2 months · monthly snapshot~Nov 2024 – present · 18 months · monthly snapshot

Change History

14 versions recorded

  1. Nov 2024 — Present [monthly]

    Terminated EARLY_PHASE1

    Status: Recruiting → Terminated

  2. Sep 2024 — Nov 2024 [monthly]

    Recruiting EARLY_PHASE1

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting EARLY_PHASE1

  4. May 2023 — Jul 2024 [monthly]

    Recruiting EARLY_PHASE1

  5. Nov 2022 — May 2023 [monthly]

    Recruiting EARLY_PHASE1

    Status: Unknown Status → Recruiting

▶ Show 9 earlier versions

  1. Jan 2021 — Nov 2022 [monthly]

    Unknown Status EARLY_PHASE1

  2. Oct 2020 — Jan 2021 [monthly]

    Unknown Status EARLY_PHASE1

    Status: Not Yet Recruiting → Unknown Status

  3. May 2019 — Oct 2020 [monthly]

    Not Yet Recruiting EARLY_PHASE1

  4. Sep 2018 — May 2019 [monthly]

    Not Yet Recruiting EARLY_PHASE1

  5. Jul 2018 — Sep 2018 [monthly]

    Not Yet Recruiting EARLY_PHASE1

  6. Jun 2018 — Jul 2018 [monthly]

    Not Yet Recruiting EARLY_PHASE1

  7. Nov 2017 — Jun 2018 [monthly]

    Not Yet Recruiting EARLY_PHASE1

  8. Feb 2017 — Nov 2017 [monthly]

    Not Yet Recruiting EARLY_PHASE1

    Phase: Phase 0 → EARLY_PHASE1

  9. Jan 2017 — Feb 2017 [monthly]

    Not Yet Recruiting Phase 0

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Lakehead University
  • St. Joseph's Care Group
  • Thunder Bay Regional Health Research Institute
  • Thunder Bay Regional Health Sciences Centre
Data source: Thunder Bay Regional Health Research Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations